{"GOLD_15": {"reading": {"text": [], "viz": []}, "mind_map": {"text": {"nodes": {}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 2}, "whatActionBox": {"key": "whatActionBox", "children": {"new_to_old": {"key": "new_to_old", "children": {}, "size": 30}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 30}}, "size": 4}}, "size": 6}}}}}, "GOLD_31": {"reading": {"text": ["vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "sosei-heptares-hits-milestone-in-pfizer-collaboration"], "viz": ["thromboembolic-events-don-t-appear-higher-in-vaccinated-population-ema-says"]}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners": {"key": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "size": 30}, "sosei-heptares-hits-milestone-in-pfizer-collaboration": {"key": "sosei-heptares-hits-milestone-in-pfizer-collaboration", "size": 30}}, "size": 4}}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whyPositiveBox": {"key": "whyPositiveBox", "children": {"consistent": {"key": "consistent", "children": {"thromboembolic-events-don-t-appear-higher-in-vaccinated-population-ema-says": {"key": "thromboembolic-events-don-t-appear-higher-in-vaccinated-population-ema-says", "size": 30}}, "size": 2}}, "size": 2}, "whereBox": {"key": "whereBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 4}}, "size": 4}, "whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 21}}, "size": 2}}, "size": 8}}}}}, "GOLD_14": {"reading": {"text": [], "viz": []}, "mind_map": {"text": {"nodes": {}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 6}, "whatTopicBox": {"key": "whatTopicBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 2}}, "size": 8}, "whereBox": {"key": "whereBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 10}}, "size": 8}, "whyPositiveBox": {"key": "whyPositiveBox", "children": {"new_to_old": {"key": "new_to_old", "children": {}, "size": 2}}, "size": 2}}, "size": 24}}}}}, "GOLD_17": {"reading": {"text": [], "viz": []}, "mind_map": {"text": {"nodes": {}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 2}, "whatActionBox": {"key": "whatActionBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 1}}, "size": 2}}, "size": 4}}}}}, "GOLD_12": {"reading": {"text": ["vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids"], "viz": []}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners": {"key": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "size": 30}, "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {"key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "size": 30}}, "size": 4}}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 6}, "whereBox": {"key": "whereBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 20}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 2}}, "size": 8}, "whatTopicBox": {"key": "whatTopicBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 8}, "consistent": {"key": "consistent", "children": {}, "size": 2}, "new_to_old": {"key": "new_to_old", "children": {}, "size": 2}}, "size": 10}, "whatActionBox": {"key": "whatActionBox", "children": {"new_to_old": {"key": "new_to_old", "children": {}, "size": 4}}, "size": 2}, "whyPositiveBox": {"key": "whyPositiveBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 2}, "consistent": {"key": "consistent", "children": {}, "size": 1}}, "size": 4}}, "size": 30}}}}}, "GOLD_18": {"reading": {"text": ["uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "sosei-heptares-hits-milestone-in-pfizer-collaboration", "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "ec-signs-up-for-1-8-billion-additional-doses-of-comirnaty", "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids"], "viz": []}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"uk-study-shows-robust-vaccine-effectiveness-against-indian-strain": {"key": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "size": 30}, "sosei-heptares-hits-milestone-in-pfizer-collaboration": {"key": "sosei-heptares-hits-milestone-in-pfizer-collaboration", "size": 30}, "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days": {"key": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "size": 30}, "ec-signs-up-for-1-8-billion-additional-doses-of-comirnaty": {"key": "ec-signs-up-for-1-8-billion-additional-doses-of-comirnaty", "size": 30}, "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {"key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "size": 30}}, "size": 10}}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whatTopicBox": {"key": "whatTopicBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 1}}, "size": 2}}, "size": 2}}}}}, "GOLD_11": {"reading": {"text": [], "viz": []}, "mind_map": {"text": {"nodes": {}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 6}, "whereBox": {"key": "whereBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 6}, "whatTopicBox": {"key": "whatTopicBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 19}, "new_to_old": {"key": "new_to_old", "children": {}, "size": 2}}, "size": 10}, "whyPositiveBox": {"key": "whyPositiveBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 22}}, "size": 2}, "whatActionBox": {"key": "whatActionBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 15}, "consistent": {"key": "consistent", "children": {}, "size": 15}}, "size": 8}}, "size": 32}}}}}, "GOLD_9": {"reading": {"text": [], "viz": []}, "mind_map": {"text": {"nodes": {}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whereBox": {"key": "whereBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 30}, "new_to_old": {"key": "new_to_old", "children": {}, "size": 6}}, "size": 10}, "whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 4}, "whatTopicBox": {"key": "whatTopicBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 30}}, "size": 4}}, "size": 18}}}}}, "GOLD_2": {"reading": {"text": ["coronavirus-vaccine-approved-for-use-in-children", "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents", "march-april-2021-pharmaceutical-m-a-round-up", "sosei-heptares-hits-milestone-in-pfizer-collaboration"], "viz": ["eu-sues-vaccine-developer-while-usa-donates-excess-supplies"]}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"coronavirus-vaccine-approved-for-use-in-children": {"key": "coronavirus-vaccine-approved-for-use-in-children", "size": 30}, "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales": {"key": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "size": 30}, "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners": {"key": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "size": 16}, "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents": {"key": "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents", "size": 11}, "march-april-2021-pharmaceutical-m-a-round-up": {"key": "march-april-2021-pharmaceutical-m-a-round-up", "size": 5}, "sosei-heptares-hits-milestone-in-pfizer-collaboration": {"key": "sosei-heptares-hits-milestone-in-pfizer-collaboration", "size": 2}}, "size": 12}}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {"eu-sues-vaccine-developer-while-usa-donates-excess-supplies": {"key": "eu-sues-vaccine-developer-while-usa-donates-excess-supplies", "size": 7}}, "size": 30}}, "size": 8}, "whatTopicBox": {"key": "whatTopicBox", "children": {"new_to_old": {"key": "new_to_old", "children": {}, "size": 21}}, "size": 2}, "whereBox": {"key": "whereBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 7}, "new_to_old": {"key": "new_to_old", "children": {}, "size": 1}}, "size": 4}, "whyPositiveBox": {"key": "whyPositiveBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 7}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 3}}, "size": 4}, "whyNegativeBox": {"key": "whyNegativeBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 4}}, "size": 2}}, "size": 20}}}}}, "GOLD_19": {"reading": {"text": [], "viz": []}, "mind_map": {"text": {"nodes": {}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 2}}, "size": 2}}}}}, "GOLD_4": {"reading": {"text": ["pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "record-breaking-sales-of-24-8bn-by-2021-predicted-for-pfizer-biontech-s-vaccine", "trial-in-children-could-help-increase-vaccine-coverage", "vaccines-seem-effective-against-brazilian-variant"], "viz": []}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales": {"key": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "size": 30}, "record-breaking-sales-of-24-8bn-by-2021-predicted-for-pfizer-biontech-s-vaccine": {"key": "record-breaking-sales-of-24-8bn-by-2021-predicted-for-pfizer-biontech-s-vaccine", "size": 4}, "trial-in-children-could-help-increase-vaccine-coverage": {"key": "trial-in-children-could-help-increase-vaccine-coverage", "size": 3}, "vaccines-seem-effective-against-brazilian-variant": {"key": "vaccines-seem-effective-against-brazilian-variant", "size": 3}}, "size": 8}}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 4}, "whatActionBox": {"key": "whatActionBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 29}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 6}}, "size": 4}, "whereBox": {"key": "whereBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 14}}, "size": 2}}, "size": 10}}}}}, "GOLD_3": {"reading": {"text": [], "viz": ["ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots"]}, "mind_map": {"text": {"nodes": {}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whyNegativeBox": {"key": "whyNegativeBox", "children": {"consistent": {"key": "consistent", "children": {"ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots": {"key": "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots", "size": 30}}, "size": 30}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 12}, "new_to_old": {"key": "new_to_old", "children": {}, "size": 5}}, "size": 16}, "whereBox": {"key": "whereBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 14}}, "size": 12}, "whatActionBox": {"key": "whatActionBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 30}, "new_to_old": {"key": "new_to_old", "children": {}, "size": 3}, "consistent": {"key": "consistent", "children": {}, "size": 1}}, "size": 10}, "whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 6}, "whatTopicBox": {"key": "whatTopicBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 15}, "new_to_old": {"key": "new_to_old", "children": {}, "size": 4}}, "size": 4}, "whyPositiveBox": {"key": "whyPositiveBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 18}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 1}}, "size": 8}}, "size": 56}}}}}, "GOLD_24": {"reading": {"text": ["pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents"], "viz": ["full-program-for-astrazeneca-at-asco-2021", "eu-sues-vaccine-developer-while-usa-donates-excess-supplies", "full-program-for-astrazeneca-at-asco-2021", "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots"]}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days": {"key": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "size": 30}, "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain": {"key": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "size": 30}, "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents": {"key": "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents", "size": 30}}, "size": 6}}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whereBox": {"key": "whereBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 30}, "consistent": {"key": "consistent", "children": {}, "size": 22}}, "size": 12}, "whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 30}}, "size": 6}, "whyPositiveBox": {"key": "whyPositiveBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 21}, "new_to_old": {"key": "new_to_old", "children": {}, "size": 9}, "consistent": {"key": "consistent", "children": {"ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots": {"key": "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots", "size": 1}}, "size": 17}}, "size": 16}, "whatActionBox": {"key": "whatActionBox", "children": {"consistent": {"key": "consistent", "children": {"eu-sues-vaccine-developer-while-usa-donates-excess-supplies": {"key": "eu-sues-vaccine-developer-while-usa-donates-excess-supplies", "size": 5}, "full-program-for-astrazeneca-at-asco-2021": {"key": "full-program-for-astrazeneca-at-asco-2021", "size": 4}}, "size": 25}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 6}}, "size": 12}, "whatTopicBox": {"key": "whatTopicBox", "children": {"consistent": {"key": "consistent", "children": {"full-program-for-astrazeneca-at-asco-2021": {"key": "full-program-for-astrazeneca-at-asco-2021", "size": 8}}, "size": 25}, "new_to_old": {"key": "new_to_old", "children": {}, "size": 2}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 2}}, "size": 12}, "whyNegativeBox": {"key": "whyNegativeBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 14}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 2}}, "size": 4}}, "size": 62}}}}}, "GOLD_28": {"reading": {"text": ["pfizer-and-biontech-initiate-fda-rolling-bla-submission-for-their-covid-19-vaccine", "coronavirus-vaccine-approved-for-use-in-children", "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "latest-pfizer-biontech-results-offer-youthful-optimism", "trial-in-children-could-help-increase-vaccine-coverage"], "viz": []}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"pfizer-and-biontech-initiate-fda-rolling-bla-submission-for-their-covid-19-vaccine": {"key": "pfizer-and-biontech-initiate-fda-rolling-bla-submission-for-their-covid-19-vaccine", "size": 30}, "coronavirus-vaccine-approved-for-use-in-children": {"key": "coronavirus-vaccine-approved-for-use-in-children", "size": 30}, "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales": {"key": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "size": 23}, "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {"key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "size": 21}, "latest-pfizer-biontech-results-offer-youthful-optimism": {"key": "latest-pfizer-biontech-results-offer-youthful-optimism", "size": 19}, "trial-in-children-could-help-increase-vaccine-coverage": {"key": "trial-in-children-could-help-increase-vaccine-coverage", "size": 17}}, "size": 12}}}, "viz": {"nodes": {}}}}, "GOLD_16": {"reading": {"text": ["uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "pfizer-takes-aim-at-coronavirus-and-vaccines-market", "vaccines-seem-effective-against-brazilian-variant", "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids"], "viz": []}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"uk-study-shows-robust-vaccine-effectiveness-against-indian-strain": {"key": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "size": 30}, "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days": {"key": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "size": 29}, "pfizer-takes-aim-at-coronavirus-and-vaccines-market": {"key": "pfizer-takes-aim-at-coronavirus-and-vaccines-market", "size": 20}, "vaccines-seem-effective-against-brazilian-variant": {"key": "vaccines-seem-effective-against-brazilian-variant", "size": 19}, "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {"key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "size": 11}}, "size": 10}}}, "viz": {"nodes": {}}}}, "GOLD_20": {"reading": {"text": ["latest-pfizer-biontech-results-offer-youthful-optimism", "pfizer-expands-anti-infectives-pipeline-with-acquisition"], "viz": []}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"latest-pfizer-biontech-results-offer-youthful-optimism": {"key": "latest-pfizer-biontech-results-offer-youthful-optimism", "size": 17}, "pfizer-expands-anti-infectives-pipeline-with-acquisition": {"key": "pfizer-expands-anti-infectives-pipeline-with-acquisition", "size": 4}}, "size": 4}}}, "viz": {"nodes": {"astrazeneca": {"key": "astrazeneca", "children": {"whoBox": {"key": "whoBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 17}}, "size": 2}, "whereBox": {"key": "whereBox", "children": {"consistent": {"key": "consistent", "children": {}, "size": 12}, "old_to_new": {"key": "old_to_new", "children": {}, "size": 4}}, "size": 4}, "whatTopicBox": {"key": "whatTopicBox", "children": {"old_to_new": {"key": "old_to_new", "children": {}, "size": 1}}, "size": 2}}, "size": 8}}}}}, "GOLD_30": {"reading": {"text": ["myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "pfizer-takes-aim-at-coronavirus-and-vaccines-market"], "viz": []}, "mind_map": {"text": {"nodes": {"pfizer": {"key": "pfizer", "children": {"myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids": {"key": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "size": 16}, "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain": {"key": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "size": 13}, "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days": {"key": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "size": 12}, "pfizer-takes-aim-at-coronavirus-and-vaccines-market": {"key": "pfizer-takes-aim-at-coronavirus-and-vaccines-market", "size": 7}}, "size": 8}}}, "viz": {"nodes": {}}}}}